- Home
- ATHA vs NB Comparison
ATHA vs NB Comparison
Compare ATHA & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHA
- NB
- Stock Information
- Founded
- ATHA 2011
- NB 1987
- Country
- ATHA United States
- NB United States
- Employees
- ATHA N/A
- NB N/A
- Industry
- ATHA Medicinal Chemicals and Botanical Products
- NB Metal Mining
- Sector
- ATHA Health Care
- NB Basic Materials
- Exchange
- ATHA Nasdaq
- NB Nasdaq
- Market Cap
- ATHA 93.5M
- NB 63.3M
- IPO Year
- ATHA 2020
- NB N/A
- Fundamental
- Price
- ATHA $0.54
- NB $1.65
- Analyst Decision
- ATHA Buy
- NB Strong Buy
- Analyst Count
- ATHA 3
- NB 1
- Target Price
- ATHA $22.00
- NB $8.00
- AVG Volume (30 Days)
- ATHA 1.5M
- NB 64.1K
- Earning Date
- ATHA 08-01-2024
- NB 09-13-2024
- Dividend Yield
- ATHA N/A
- NB N/A
- EPS Growth
- ATHA N/A
- NB N/A
- EPS
- ATHA N/A
- NB N/A
- Revenue
- ATHA N/A
- NB N/A
- Revenue This Year
- ATHA N/A
- NB N/A
- Revenue Next Year
- ATHA N/A
- NB N/A
- P/E Ratio
- ATHA N/A
- NB N/A
- Revenue Growth
- ATHA N/A
- NB N/A
- 52 Week Low
- ATHA $0.52
- NB $1.62
- 52 Week High
- ATHA $4.30
- NB $5.20
- Technical
- Relative Strength Index (RSI)
- ATHA 15.43
- NB 39.87
- Support Level
- ATHA $3.17
- NB $1.67
- Resistance Level
- ATHA $3.34
- NB $1.87
- Average True Range (ATR)
- ATHA 0.24
- NB 0.17
- MACD
- ATHA -0.32
- NB -0.04
- Stochastic Oscillator
- ATHA 0.72
- NB 0.00
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is a pure play critical minerals project in Nebraska that plans to produce niobium, scandium, titanium, and magnetic rare earths. The Elk Creek Project is the highest-grade Niobium project under development in North America and is the second largest indicated or rare earth Mineral Resource in the United States. All of NioCorp's planned products are designed as critical by the United States Government. All are vital to clean technologies and the global energy transition.